Cytori reports reduction in fibrosis parameters in scar study
Cytori announced publication of preclinical data from a study using Cytori Cell Therapy™ in a model of fibrotic scar formation. This study was performed with support from the BARDA as a component of the preclinical proof of concept data package incorporated into the FDA approved U.S. RELIEF Trial. November 20, 2017